Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolomic analysis of Maoto (TJ-27) in healthy volunteers
jRCT1080223758Phase 1Completed
- Sponsor
- Tsumura & Co.
- Start
- Dec 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of maoto extract in influenza and nasopharyngitis, sponsored by Tsumura & Co. Primary endpoint: Metabolomic profile of Maoto (TJ-27). Started Dec 2017; status: completed.
02
Drugs
maoto extract
03
Conditions
influenzanasopharyngitis
Beyond the preview
Go deeper on jRCT1080223758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223758.